AMTXNasdaqIndustrial Organic ChemicalsFiscal year ends December 31
AEMETIS, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.37−0.09 (-6.16%)
Close on Oct 19, 2026
- Market cap
- $97.11M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
-0.4%−7.0 pts over 5 years
Operating margin
-18.8%−15.2 pts over 5 years
Net margin
-39.0%−16.8 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -26.2% | +91.6% | +3.6% | +3.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 36.7% | 21.6% | 27.0% | |
| Return on assets | -19.4% | -32.6% | -29.7% | |
| Current ratio | 0.26 | 0.08 | 0.07 | |
| Debt to equity | -2.24 | -1.24 | -1.24 | |
| Net debt to EBITDA | – | -195.75× | -13.66× | |
| Interest coverage | -0.0× | -0.3× | -0.7× | |
| Inventory turnover | 32.7× | 29.5× | 10.7× | |
| Capex to revenue | 0.4% | 11.7% | 13.2% | |
| Diluted shares | 0M | 21M | 60M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Aemetis generated $93.53M from operations and spent $145.18M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$93.53M
Used
$145.18M
Capital expenditure$145.18M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-39.0%
×Asset turnover0.76×
×Equity multiplier-0.91×
=Return on equity, FY202527.0%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -39.0% | 0.76× | -0.91× | 27.0% |
| FY2024 | -32.7% | 1.06× | -1.05× | 36.4% |
| FY2023 | -24.9% | 0.83× | -1.08× | 22.2% |
| FY2022 | -383.3% | 0.15× | -1.14× | 66.9% |
| FY2021 | -22.2% | 1.48× | -0.94× | 30.9% |
| FY2020 | -22.1% | 1.47× | -0.66× | 21.6% |
| FY2019 | -19.5% | 2.11× | -0.71× | 29.2% |
| FY2018 | -21.2% | 1.84× | -0.96× | 37.4% |
| FY2017 | -21.2% | 1.74× | -1.34× | 49.6% |
| FY2016 | -10.9% | 1.78× | -1.89× | 36.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$77.00M
- Cash generatingOperating cash flow above zero$3.26M
- Return on assets improvedROA up on the prior year-36.0% → -29.7%
- Earnings backed by cashOperating cash flow above net income$3.26M vs -$77.00M
- Less leverageLong-term debt to assets fell95.5% → 24.6%
- Better liquidityCurrent ratio rose0.31 → 0.07
- No dilutionShare count did not rise46M → 60M
- Gross margin improvedGross margin up on the prior year-0.22% → -0.39%
- More efficientAsset turnover rose1.10 → 0.76